Joep de Bruijne
- Hepatology top 2%
- Hepatitis C virus research 24
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 6
- Speech and Hearing top 2%
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 14
- Genetics top 5%
- Gastroenterology top 5%
-
- HIV/AIDS drug development and treatment 7
- Viral gastroenteritis research and epidemiology 4
-
- Renal cell carcinoma treatment 6
- Co-authors
- Mary ZachosDavid R. MackPetar MamulaThomas D. WaltersKrista UusoueDan TurnerJeffrey S. HyamsAnne M. Griffiths
- Partner nations
- NetherlandsUnited StatesCanada
In The Last Decade
Joep de Bruijne
45 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 464
- Speech and Hearing 155
- Epidemiology 754
- Genetics 600
- Gastroenterology 74
Countries citing papers authored by Joep de Bruijne
This map shows the geographic impact of Joep de Bruijne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joep de Bruijne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joep de Bruijne more than expected).
Fields of papers citing papers by Joep de Bruijne
This network shows the impact of papers produced by Joep de Bruijne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joep de Bruijne. The network helps show where Joep de Bruijne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joep de Bruijne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 15 | |
| 10 | 2018 | 6 | |
| 11 | 2018 | 10 | |
| 12 | 2015 | 125 | |
| 13 | 2013 | 6 | |
| 14 | 2011 | 6 | |
| 15 | 2011 | 3 | |
| 16 | 2011 | 43 | |
| 17 | 2010 | 24 | |
| 18 | 2009 | 12 | |
| 19 | 2008 | 5 | |
| 20 | Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Studybreakdown → | 2007 | 788 |
About Joep de Bruijne
Joep de Bruijne is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), HIV/AIDS drug development and treatment (7 papers), Renal cell carcinoma treatment (6 papers), Liver Disease and Transplantation (6 papers) and Viral gastroenteritis research and epidemiology (4 papers). The work is most often cited by research in Hepatology (464 citations), Speech and Hearing (155 citations) and Epidemiology (754 citations). Joep de Bruijne has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Mary Zachos, David R. Mack, Petar Mamula, Thomas D. Walters, Krista Uusoue, Dan Turner, Jeffrey S. Hyams, Anne M. Griffiths, A. Hillary Steinhart and Dorcas Beaton. Their work appears in journals such as Gastroenterology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.